Great Point Partners LLC Ionis Pharmaceuticals Inc Transaction History
Great Point Partners LLC
- $152 Million
- Q4 2024
A detailed history of Great Point Partners LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Great Point Partners LLC holds 505,007 shares of IONS stock, worth $16.5 Million. This represents 11.64% of its overall portfolio holdings.
Number of Shares
505,007
Previous 255,000
98.04%
Holding current value
$16.5 Million
Previous $10.2 Million
72.83%
% of portfolio
11.64%
Previous 4.72%
Shares
8 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$539 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$464 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$375 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$338 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$284 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.65B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...